1. Home
  2. CVE vs NTRA Comparison

CVE vs NTRA Comparison

Compare CVE & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cenovus Energy Inc

CVE

Cenovus Energy Inc

HOLD

Current Price

$21.55

Market Cap

34.6B

Sector

Energy

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$208.40

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVE
NTRA
Founded
2009
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.6B
32.9B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CVE
NTRA
Price
$21.55
$208.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
14
Target Price
$26.00
$253.79
AVG Volume (30 Days)
12.8M
1.1M
Earning Date
02-19-2026
02-27-2026
Dividend Yield
2.56%
N/A
EPS Growth
N/A
N/A
EPS
1.23
N/A
Revenue
$37,063,946,178.00
$2,116,676,000.00
Revenue This Year
N/A
$33.95
Revenue Next Year
N/A
$16.72
P/E Ratio
$17.83
N/A
Revenue Growth
N/A
38.17
52 Week Low
$10.23
$125.38
52 Week High
$22.20
$256.36

Technical Indicators

Market Signals
Indicator
CVE
NTRA
Relative Strength Index (RSI) 64.76 39.17
Support Level $21.19 $204.04
Resistance Level $22.20 $213.96
Average True Range (ATR) 0.72 8.97
MACD 0.13 -1.58
Stochastic Oscillator 80.49 31.36

Price Performance

Historical Comparison
CVE
NTRA

About CVE Cenovus Energy Inc

Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: